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Abstract 
Mycosis fungoides (MF) is an uncommon primary cutaneous lymphoma with a wide 
spectrum of clinicopathological manifestations. Diagnosis can be difficult in its early 
stages given the considerable overlap with more common benign dermatoses. We report 
an unusual case of MF in a 52-year-old male presenting with psoriasiform plaques on the 
palms and the soles who rapidly developed additional lesions on the scalp, limps and 
trunk. Punch biopsy of the face was obtained for routine histology and 
immunohistochemical stains. Chest X-ray, total body computed tomography scanning 
and excisional biopsy of the inguinal lymph node were performed. Review of the face 
biopsy revealed a diffuse dermal infiltrate containing a high number of atypical 
lymphocytes showing a CD3+, CD4+, CD45RO+, CD8–, CD20– immunophenotype and 
epidermotropism. Findings were consistent with tumor stage MF (stage IIB, T3 N1 M0). 
We report a rare presentation of MF mimicking psoriasis vulgaris. 
 
Introduction 
Mycosis fungoides (MF) is the commonest variant of primary cutaneous T cell 
lymphoma, accounting for almost 50% of all primary cutaneous lymphomas [1, 2]. It 
most commonly affects middle-aged and elderly adults of all races [3]. Typically, 
neoplastic T cells localize to the skin and produce patches, plaques, tumors or 
erythroderma [4]. It is characterized by a relatively consistent constellation of clinical, 
histologic, immunophenotypic and molecular aberrations [5]. 
MF typically manifests as an indolent cutaneous eruption with erythematous scaly 
patches or plaques and may progress to generalized erythroderma, cutaneous tumors, or 
extracutaneous involvement. The initial skin lesions are often confined to sunprotected 
areas. The rate of progression is unpredictable. Tumors, however, develop only in a 
minority of patients from patches, plaques, or de novo. They more commonly arise on the  
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face and body folds. Leonine facies results from malignant T cell infiltration leading to 
extensive thickening and skin fold accentuation. The palms and soles can develop 
hyperkeratosis and skin fissuring. These phases may be distinct or overlapping at 
diagnosis [6, 7]. Classically, MF shows a CD2+, CD3+, CD4+, CD8–, CD30–, CD45RO+ 
immunophenotype. Rare cases with a T suppressor CD8+/CD4– phenotype have been 
reported [8, 9]. This report describes the clinical, histopathologic and 
immunohistochemical features of a patient with MF mimicking psoriasis vulgaris. 
Case Report 
A 52-year-old white man was referred to the Department of Dermatology, University of Palermo 
(Italy) with a six-month history of psoriasiform plaques with superficial erosion and fissuring on the 
palms (fig. 1b) and the soles. Within a few weeks red violet and infiltrated plaques with moderate 
hyperkeratosis and scaling developed on the scalp and upper limps accompanied by itching. The patient 
was misdiagnosed as having psoriasis vulgaris. Various mid- and high-potency topical corticosteroids 
did not offer significant relief. Four months prior to referral he developed red to violaceous nodules 
which coalesced to form large plaques on the face. Skin examination at the time of hospital admission, 
approximately six months from the onset of his illness, revealed reddish brown ulcerated tumors and 
indurated erythematous plaques with superficial erosion on the forehead, glabella, cheeks (fig. 1a), scalp 
and neck. In addition, numerous plaques, accompanied by itching, were found on trunk and extremities 
in a generalized distribution. Plaques appeared as sharply delineated, scaly, elevated lesions that were 
dusky red to violaceous and variably indurated (fig. 1c). His nails were intact without pitting or 
dystrophy. He had cervical, scalp, neck, axial and inguinal lymphadenopathy. His chest was clear on 
auscultation. There was no hepatosplenomegaly and his abdomen was soft with normal bowel sounds. 
His cardiovascular, musculoskeletal and neurological exams were normal. His past medical history was 
unremarkable. He was not on medications. There was no history of anorexia, weight loss, fever or night 
sweats. The blood count showed normal red cell count and a slight leukocytosis (11.42 × 10
3/μl) 
comprised of 74.6% neutrophils, 7.2% eosinophils, 0.7% basophils, 11.1% lymphocytes and 6.4% 
monocytes. Further laboratory investigations of the blood showed alpha 1-globulin 5.25% and an 
erythrocyte sedimentation rate of 44 mm/h. Chemistry and liver function tests were unremarkable.  
A biopsy specimen was obtained from affected areas of the face, fixed in 10% buffered formalin and 
embedded in paraffin. For routine histology, 5-μm-thick sections were stained with hematoxylin and 
eosin. Immunohistochemical stains were performed according to the markers presented in table 1. 
Chest X-ray, total body computed tomography scanning and excisional biopsy of the inguinal lymph 
node were obtained. 
Results 
Review of the face biopsy on hematoxylin and eosin showed a dense, partly 
subepidermal and band-like, partly perivascular and periadnexal dermal infiltrate (fig. 2a) 
containing a high number of atypical lymphocytes, eosinophils, plasma cells and 
macrophages. Many of the lymphocytes were pleomorphic, hyperchromatic, 
hyperconvoluted and had an increased cytoplasmic to nuclear ratio. Their nuclei were 
moderately irregular showing several mitoses (fig. 2b). Epidermotropism was prominent 
with small intraepidermal clusters of lymphocytes forming Pautrier’s microabsesses. Mild 
acanthosis, hyperkeratosis, basal layer damage, edema and fibrosis of the papillary dermis 
and moderate proliferation of postcapillary venules were also seen. Immunohistologically 
the malignant cells expressed a mature peripheral T cell phenotype (CD3+, CD4+, 
CD45RO+, CD8–, CD20–) (fig. 2c–d). Chest X-ray and ultrasonography of the abdomen 
were without pathological findings. Peripheral blood film for Sézary cells was negative. 
Total body computed tomography scanning was obtained documenting retroauricular, 
occipital, deep cervical lymphatic chain, submandibular, submental, axillary, subclavian 
and inguinal enlarged lymph nodes without visceral involvement. An excisional biopsy of  
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the inguinal lymph node showed dermatopathic and reactive lymphadenitis. Findings 
were consistent with tumor stage MF (stage IIB, T3 N1 M0). 
Discussion 
MF is generally an indolent malignancy, with slow progression over years or even 
decades [10]. The onset of the disease is often insidious and initial cutaneous symptoms 
may be difficult to distinguish from various inflammatory dermatoses such as chronic 
eczema, psoriasis, atopic dermatitis, etc. [8, 11]. As the disease progresses, patches may 
evolve over a variable period of time into infiltrated plaques with a more generalized 
distribution. Plaques can be followed by ulcerated and exophytic tumors. Tumors develop 
only in a minority of patients, although it is common to have patch, plaque and tumor 
lesions simultaneously on different parts of the body. Some patient with patch stage MF 
never progress to other forms of the disease. Tumors are the presenting sign in about 10% 
of cases. Lymphadenopathy is usually a late occurrence. Visceral dissemination (lungs, 
spleen, liver, gastrointestinal tract) may develop subsequently. Extracutaneous 
dissemination is directly correlated to the extent of cutaneous disease [7, 10]. 
We report a patient who first showed hyperkeratotic psoriasiform plaques on the 
palms and soles. Involvement of the palms and/or soles occurs at some time during the 
course of the disease in 11.5% of patients. Mycosis fungoides palmaris et plantaris is a rare 
variant of MF-type cutaneous T cell lymphoma predominantly affecting or initially 
presenting on the palms and/or soles. Sometimes the lesions may extend to the fingers, 
arms and feet. The prevalence of mycosis fungoides palmaris et plantaris among MF 
patients is 0.6%. In most cases the disease shows a benign course; the lesions remain 
confined to the initial areas without dissemination and extracutaneous spread [12, 13]. 
In our patient tumors in the skin and lymphadenopathy developed rapidly over a 
two-month time span without lengthy preceding erythematous or plaque stages. The 
initial lesions of MF usually develop in the fifth and sixth decades. The time interval 
between onset of skin changes and definite pathologic diagnosis of MF is 4–6 years 
[10, 14]. In the present case the lesions developed into a leonine clinical appearance of the 
face accompanied by lymphadenopathy, which reminded us the tumor stage MF. Clinical, 
histopathological and immunohistochemical findings revealed an atypical case of MF. 
Based on the early involvement of extracutaneous sites, the course of this patient may be 
more aggressive than typical patch-stage disease, in which mortality is not significantly 
different from matched controls. The presence of tumor stage disease is associated with a 
worse prognosis (stage IIB: median survival of 2.9 years) [15]. 
MF is an uncommon lymphoma with a wide spectrum of clinicopathological 
manifestations and unpredictable course. Diagnosis can be difficult in its early stages 
given the considerable overlap with more common benign dermatoses. 
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Table 1. Summary of immunohistochemical methods and results 
Antibody Clone  Supplier  Dilution  Incubation 
time, min 
Retrieval Results 
CD3 PC3/188A  Dako  prediluted 40  15  min  positive 
CD4  Edu-2  NovoCastra   1:50  60  30 min  positive 
CD8 C8/144B  Dako  prediluted  30 60  min  negative 
CD20 L26  Dako  prediluted  35  60  min  negative 
CD45RO UCHL-1  Biogenex  1:75  30 50  min  positive 
 
 
 
 
Fig. 1. Erythematous plaques with superficial erosion on the face (a), psoriasiform plaques with 
superficial erosion and fissuring on the palms (b) and sharply delineated plaques on trunk (c). 
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Fig. 2. a Histopathology of a skin biopsy showed a dense band-like dermal infiltrate (H&E, original 
magnification ×125). b Abnormal lymphocytes with moderately irregular nuclei showing several 
mitoses (H&E, original magnification ×640). c Immunoreactivity for CD45RO (original magnification 
×160). d Immunoreactivity for CD45RO (original magnification ×500). 
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